Fukuda N, Toda K, Wang X, Ohmoto A, et al. Prognostic significance of 8 weeks' relative dose intensity of lenvatinib in treatment of radioiodine-refractory differentiated thyroid cancer patients. Endocr J 2021 Jan 28. doi: 10.1507/endocrj.EJ20-0754.
PMID: 33504716